nafamostat has been researched along with Shock, Cardiogenic in 2 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morishima, I | 1 |
| Sassa, H | 1 |
| Sone, T | 1 |
| Tsuboi, H | 1 |
| Kondo, J | 1 |
| Koyama, T | 1 |
| Tanaka, K | 1 |
| Sato, T | 1 |
| Kondo, C | 1 |
| Yada, I | 1 |
| Yuasa, H | 1 |
| Kusagawa, M | 1 |
| Nasu, M | 1 |
| Okada, Y | 1 |
| Shomura, T | 1 |
2 other studies available for nafamostat and Shock, Cardiogenic
| Article | Year |
|---|---|
A case of fulminant myocarditis rescued--by long-term percutaneous cardiopulmonary support.
Topics: Acute Disease; Adult; Antithrombins; Benzamidines; Complement Inactivator Proteins; Guanidines; Hear | 1994 |
Hematological problems during the use of cardiac assist devices: clinical experiences in Japan.
Topics: Aged; Anticoagulants; Antithrombin III; Benzamidines; Blood Coagulation; Female; Fibrinopeptide A; G | 1992 |